Viking Global Investors LP Pharvaris N.V. Transaction History
Viking Global Investors LP
- $25.1 Billion
- Q2 2024
A detailed history of Viking Global Investors LP transactions in Pharvaris N.V. stock. As of the latest transaction made, Viking Global Investors LP holds 3,653,310 shares of PHVS stock, worth $67.7 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
3,653,310
Previous 3,653,310
-0.0%
Holding current value
$67.7 Million
Previous $84.4 Million
18.65%
% of portfolio
0.27%
Previous 0.32%
Shares
9 transactions
Others Institutions Holding PHVS
# of Institutions
36Shares Held
37.8MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$139 Million4.48% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.29MShares$79.5 Million54.23% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$79.4 Million45.57% of portfolio
-
Vr Adviser, LLC New York, NY3.4MShares$62.9 Million7.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$61.2 Million12.7% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $625M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...